IQROSMA Trademark

Trademark Overview


On Monday, January 24, 2022, a trademark application was filed for IQROSMA with the United States Patent and Trademark Office. The USPTO has given the IQROSMA trademark a serial number of 97235603. The federal status of this trademark filing is REGISTERED as of Tuesday, June 6, 2023. This trademark is owned by Glaxo Group Limited. The IQROSMA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
iqrosma

General Information


Serial Number97235603
Word MarkIQROSMA
Filing DateMonday, January 24, 2022
Status700 - REGISTERED
Status DateTuesday, June 6, 2023
Registration Number7071929
Registration DateTuesday, June 6, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 10, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Thursday, November 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 6, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 6, 2023REGISTERED-PRINCIPAL REGISTER
Sunday, April 30, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, January 2, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 2, 2022ASSIGNED TO EXAMINER
Friday, January 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 27, 2022NEW APPLICATION ENTERED